Clinical Trial Update: Efficacy and Safety of Pegzilarginase in Patients With Arginase 1 Deficiency [Phase 3]

View source ↗

Summary

Phase 3 results evaluating Pegzilarginase for Arginase I Deficiency (hyperargininemia) have been posted after completion of the study, detailing efficacy and sa…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Arginase Deficiency
• Hyperargininemia

Drugs mentioned

• Pegzilarginase (pegzilarginase)

Snippet

Sponsor: Aeglea Biotherapeutics | Conditions: Arginase I Deficiency, Hyperargininemia | Phase 3 | Status: COMPLETED | Results posted: 2024-11-19